More tools:Markets·Screener·Research·Chat

STERIS plc (STE) Financial Statements

STERIS plc
SIC 3842 · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
FIGI BBG00MRHG532
XNYS · usd
238.00▼ 0.23 (-0.10%)
As of 2026-08-12
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)$5.9B
Net Income (TTM)$782.3M
EBITDA
Diluted EPS (TTM)
EBITDA Margin26.8%
Net Debt
Trading Information
Previous Close238.23
Day's Range237.13 – 241.39
52-Week Range195.14 – 269.44
Volume651.5K
Avg Volume756.6K
Share Statistics
Shares Outstanding97.8M
Employees17.8K
ExchangeXNYS
Listed1992-06-02
Loading Income Statement…
Key questions about STERIS plc (STE)
What is STERIS plc's Market Cap?
STERIS plc's Market Cap is $23.3B, based on as-reported figures from SEC (XBRL) filings.
What is STERIS plc's Enterprise Value?
STERIS plc's Enterprise Value is $24.8B, based on as-reported figures from SEC (XBRL) filings.
What is STERIS plc's Trailing P/E?
STERIS plc's Trailing P/E is 29.8×, based on as-reported figures from SEC (XBRL) filings.
What is STERIS plc's Price / Sales?
STERIS plc's Price / Sales is 3.9×, based on as-reported figures from SEC (XBRL) filings.
What is STERIS plc's EV / Revenue?
STERIS plc's EV / Revenue is 4.2×, based on as-reported figures from SEC (XBRL) filings.
What is STERIS plc's EV / EBITDA?
STERIS plc's EV / EBITDA is 15.6×, based on as-reported figures from SEC (XBRL) filings.
What is STERIS plc's Revenue (TTM)?
STERIS plc's Revenue (TTM) is $5.9B, based on as-reported figures from SEC (XBRL) filings.
What is STERIS plc's Net Income (TTM)?
STERIS plc's Net Income (TTM) is $782.3M, based on as-reported figures from SEC (XBRL) filings.
What is STERIS plc's EBITDA?
STERIS plc's EBITDA is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is STERIS plc's Diluted EPS (TTM)?
STERIS plc's Diluted EPS (TTM) is 8.00, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Revenues:
Total revenues————
YoY growth————
Cost of revenues:
Cost of revenues
Gross Profit
% of revenue————
Operating expenses:
Selling, general, and administrative
Research and development
Restructuring Costs
Total operating expenses
% of revenue————
Income (loss) from operations
% of revenue————
Non-operating expenses, net:
Interest expense
Interest income and miscellaneous expense
Other expense (income), net
Total non-operating expenses, net
Income (loss) before income tax expense (benefit)
Income tax expense (benefit)
Income from continuing operations, net of income tax
Income (loss) from discontinued operations, net of income tax
Net income
% of revenue————
Earnings Per Share, Basic—
Earnings Per Share, Diluted—